Eyeworld

SPRING 2024

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/1516463

Contents of this Issue

Navigation

Page 33 of 182

*For professional use only. ImprimisRx specializes in customizing medications to meet unique patient and practitioner needs. No compounded medication is reviewed by the FDA for safety and efficacy. ImprimisRx does not compound essential copies of commercially available products. These ingredients carry risks. Visit imprimisrx.com/productinformation for full product details. References available upon request. **Replacement guarantee applies to product that is unused and unopened. ***Same-day shipping applies to orders submitted by 3 PM EST Monday-Friday. †Beyond use date is 150 days refrigerated versus 45 days frozen based on completed stability studies. ††Every batch is tested for potency and sterility at our FDA-registered laboratory. References. 1. Data on file. 2. United States Pharmacopeia <797> Pharmaceutical compounding--sterile preparations. (2022). USP-NF, Rockville, MD. ImprimisRx and Fortisite are registered trademarks of Harrow IP, LLC. ©2024 ImprimisRx. All Rights Reserved. FORTI-00044-1 03/24 We're excited to announce the expansion of our portfolio with new and upcoming formulations. These additions join our existing Fortisite portfolio of fortified antibiotics. Additional options are now available to you and your patients. Available only from ImprimisRx® Refrigerated; Never Frozen †,1,2 100% Replacement Guarantee on Expired Product ** Quality Tested †† Customer Care 844-446-6979 Scan to order now or visit order.imprimisrx.com/fortisite Fortisite Formulations: NEW! Tobramycin 1% and Vancomycin 2.5% Ophthalmic Solution Current Tobramycin 1.5% and Vancomycin 5% Ophthalmic Solution COMING SOON! Vancomycin 2.5% Ophthalmic Solution Vancomycin 5% Ophthalmic Solution Fortified Antibiotic Ophthalmic Solution * Expanding our Fortisite® Portfolio: Same-Day Shipping and Easy Ordering ***

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - SPRING 2024